Skip to content

Coherence Analyses in Hyperkinetic Movement Disorders

Coherence Analyses in Hyperkinetic Movement Disorders - Coherence Analyses HMD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42214
Enrollment
30
Registered
2014-12-18
Start date
2015-01-09
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dystonia essential tremor. Hyperkinetic movement disorders

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients with Dystonia (DYS) or Parkinson's Disease (PD) who will be treated with DBS, and Essential Tremor (ET) patients with DBS in which the stimulator will be replaced operatively. 2. 18 years and older. 3. life expectancy longer than one year

Exclusion criteria

Exclusion criteria: Any condition with a life expectancy less then 1 year, which would result in incomplete follow-up.

Design outcomes

Primary

MeasureTime frame
In all patients: Relation between LFP-EMG coherence and clinical effect of DBS quantified by the difference pre- and post-surgery on the specific movement disorder rating scales.

Secondary

MeasureTime frame
In DYS: Cortico-muscular (EEG-EMG), intra-muscular (EMG-EMG) coherence, and *Burke-Fahn-Marsden dystonia rating scale* (BFMDRS) values pre- and post-DBS-surgery. In PD: Cortico-muscular (EEG-EMG + accelerometer) coherence, intra-muscular (EMG-EMG), and tremor severity assessed with tremor items of the motor (third) part of the unified Parkinson's disease rating scale (UPDRS) values pre- and post-DBS-surgery.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)